Table 1

Baseline subject demographic and clinical data

Baseline demographicsCRFA (N=105)SMM (N=105)
Age (mean±SD)57.8±13.655.5±13.8
Female sex (n/N (%))77/105 (77.3)78/105 (74.3)
BMI (kg/m2) (mean±SD)28.5±5.229.3±5.5
Race/ethnicity (n/N (%))
 Hispanic or Latino6/105 (5.7)0/105 (0.0)
 Non-Hispanic White92/105 (87.6)99/105 (94.3)
 Black or African American4/105 (3.8)5/105 (4.8)
 Asian3/105 (2.9)0/105 (0.0)
 Other0/105 (0.0)1/105 (1.0)
Laterality (n/N (%))
 Unilateral56/105 (53.3)54/105 (51.4)
 Bilateral49/105 (46.7)51/105 (48.6)
Duration of low back pain (months) (mean±SD)115.0±108.1123.9±131.3
Analgesic use for low back pain (n/N (%))
 Non-opioid analgesic use42/105 (40.0)43/105 (41.0)
 Opioid use41/105 (39.0)38/105 (36.2)
Lateral branch block
 % Decrease in NRS pain score (mean±SD)85.7±18.184.0±17.7
  • BMI, body mass index; CRFA, cooled radiofrequency ablation; NRS, Numeric Rating Scale; SMM, standard medical management.